Flow cytometric assessment of LDL receptor activity peripheral blood mononuclear cells compared to gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia

Citation
B. Raungaard et al., Flow cytometric assessment of LDL receptor activity peripheral blood mononuclear cells compared to gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia, CYTOMETRY, 36(1), 1999, pp. 52-59
Citations number
37
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CYTOMETRY
ISSN journal
01964763 → ACNP
Volume
36
Issue
1
Year of publication
1999
Pages
52 - 59
Database
ISI
SICI code
0196-4763(19990501)36:1<52:FCAOLR>2.0.ZU;2-T
Abstract
Background: Studies indicate that human peripheral blood mononuclear cells mirror low-density lipoprotein (LDL) receptor activity of other cells in th e body. To measure LDL receptor activity in patients with heterozygous fami lial hypercholesterolemia (FK), we prepared peripheral blood mononuclear ce lls from individuals with molecularly verified LDL receptor defective (Trp( 66)-Gly mutation, n = 18) or receptor negative (Trp(23)-stop mutation, n = 17) heterozygous FH and from healthy individuals (n = 24). Methods: The cells were stimulated to express maximum LDL receptor by prein cubation in lipoprotein-free medium. They were then incubated at 4 degrees or 37 degrees C with fluorescently conjugated LDL (DiI-LDL), T-lymphocytes and monocytes were identified by fluorescently conjugated monoclonal antibo dies. DiI-LDL bound (at 4 degrees C) or internalized (at 37 degrees C) by t he cells was measured using flow cytometry. Knowing the LDL receptor gene m utation of the FH patients allowed us to compare the diagnostic capability of our functional assay with the DNA diagnosis. Results: The diagnostic accuracy did not allow our assay to be used for dia gnosis of individual cases of heterozygous FH. Conclusions: We suggest that our two-color fluorescence flow cytometry assa y can be used to characterize functionally gene mutations causing LDL recep tor dysfunction in patients with heterozygous FH. Cytometry 36:52-59, 1999, (C) 1999 Wiley-Liss, Inc.